Miron M, Blaj M, Ristescu AI, Iosep G, Avadanei AN, Iosep DG et al (2024) Hospital-acquired pneumonia and ventilator-associated pneumonia: a literature review. Microorganisms 12. https://doi.org/10.3390/microorganisms12010213

Ranzani OT, Niederman MS, Torres A (2022) Ventilator-associated pneumonia. Intens Care Med 48:1222–1226. https://doi.org/10.1007/s00134-022-06773-3

Article  Google Scholar 

Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS (2020) Antibiotic resistance and persistence-Implications for human health and treatment perspectives. EMBO Rep 21:e51034. https://doi.org/10.15252/embr.202051034

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health Organisation (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. https://www.infobioquimica.com/new/wp-content/uploads/2017/02/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. [Accessed 2 July 2024]

Zeng M, Xia J, Zong Z, Shi Y, Ni Y, Hu F et al (2023) Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect 56:653–671. https://doi.org/10.1016/j.jmii.2023.01.017

Article  CAS  PubMed  Google Scholar 

China Antimicrobial Resistance Surveillance System (2024) 2023 national report on antimicrobial resistance surveillance. https://www.carss.cn/Report/Details/978. [Accessed 23 June 2025]

Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M et al (2021) Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis 41:1003–1022. https://doi.org/10.1007/s10096-020-04121-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhen S, Wang H, Feng S (2022) Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections. Infection 50:1409–1423. https://doi.org/10.1007/s15010-022-01876-x

Article  CAS  PubMed  Google Scholar 

Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. https://doi.org/10.1093/cid/ciae403

Article  PubMed  PubMed Central  Google Scholar 

Rabanal F, Cajal Y (2017) Recent advances and perspectives in the design and development of polymyxins. Nat Prod Rep 34:886–908. https://doi.org/10.1039/c7np00023e

Article  CAS  PubMed  Google Scholar 

Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A et al (2019) International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European Society of clinical microbiology and infectious diseases (ESCMID), infectious diseases society of America (IDSA), international society for anti-infective pharmacology (ISAP), society of critical care medicine (SCCM), and society of infectious diseases pharmacists (SIDP). Pharmacotherapy 39:10–39. https://doi.org/10.1002/phar.2209

Article  PubMed  PubMed Central  Google Scholar 

Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis 63:e61–e111. https://doi.org/10.1093/cid/ciw353

Article  PubMed  PubMed Central  Google Scholar 

LeGall JRLP (1986) Alpérovitch A APACHE II–a severity of disease classification system. Crit Care Med 14:754–764. https://doi.org/10.1097/00003246-198608000-00027

Article  CAS  PubMed  Google Scholar 

Lambden S, Laterre PF, Levy MM, Francois B (2019) The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care 23:374. https://doi.org/10.1186/s13054-019-2663-7

Article  PubMed  PubMed Central  Google Scholar 

London (2023) Acute kidney injury_prevention, detection andmanagement. https://www.niceorguk/guidance/ng148/chapter/Recommendations#assessing-risk-of-acute-kidney-injury. Accessed 2 Jul 2024

Yin Y, Zhao C, Li H, Jin L, Wang Q, Wang R et al (2021) Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: a 10-year prospective observational study in China. Eur J Clin Microbiol Infect Dis 40:683–690. https://doi.org/10.1007/s10096-020-04046-9

Article  CAS  PubMed  Google Scholar 

Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30:557–596. https://doi.org/10.1128/CMR.00064-16

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tran TB, Velkov T, Nation RL, Forrest A, Tsuji BT, Bergen PJ et al (2016) Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? Int J Antimicrob Agents 48:592–597. https://doi.org/10.1016/j.ijantimicag.2016.09.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boisson M, Gregoire N, Cormier M, Gobin P, Marchand S, Couet W et al (2017) Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients. J Antimicrob Chemother 72:2607–2612. https://doi.org/10.1093/jac/dkx167

Article  CAS  PubMed  Google Scholar 

Benitez-Cano A, de Antonio-Cusco M, Luque S, Sorli L, Carazo J, Ramos I et al (2019) Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia. J Antimicrob Chemother 74:3268–3273. https://doi.org/10.1093/jac/dkz356

Article  CAS  PubMed  Google Scholar 

Feng JY, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH et al (2021) Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant gram-negative bacterial pneumonia: a multi-centre observational study. Clin Microbiol Infect 27:1465–1473. https://doi.org/10.1016/j.cmi.2021.01.020

Article  CAS  PubMed  Google Scholar 

Almangour TA, Alruwaili A, Almutairi R, Alrasheed A, Alhifany AA, Eljaaly K et al (2021) Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: a retrospective cohort study. Int J Infect Dis 108:406–412. https://doi.org/10.1016/j.ijid.2021.06.007

Article  CAS  PubMed  Google Scholar 

Lu D, Mao W (2023) Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: a systematic review and meta-analysis. Heliyon 9:e15774. https://doi.org/10.1016/j.heliyon.2023.e15774

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vardakas KZ, Mavroudis AD, Georgiou M, Falagas ME (2018) Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: a systematic review and meta-analysis. J Infect 76:321–327. https://doi.org/10.1016/j.jinf.2018.02.002

Article  PubMed  Google Scholar 

Tang T, Li Y, Xu P, Zhong Y, Yang M, Ma W et al (2023) Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study. Crit Care 27:164. https://doi.org/10.1186/s13054-023-04448-z

Article  PubMed  PubMed Central  Google Scholar 

Hasan MJ, Rabbani R, Anam AM, Santini A, Huq SMR (2021) The susceptibility of MDR-K. Pneumoniae to polymyxin B plus its nebulised form versus polymyxin B alone in critically Ill South Asian patients. J Crit Care Med (Targu Mures) 7:28–36. https://doi.org/10.2478/jccm-2020-0044

Article  PubMed  Google Scholar 

Ghosh S, Polymyxin B (2024) Plus aerosolized colistin vs polymyxin B alone in hospital-acquired pneumonia (“AEROCOL” Study): a feasibility study. Indian J Crit Care Med 28:792–795. https://doi.org/10.5005/jp-journals-10071-24767

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sisay M, Hagos B, Edessa D, Tadiwos Y, Mekuria AN (2021) Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury. Pharmacol Res 163:105328. https://doi.org/10.1016/j.phrs.2020.105328

Article  CAS  PubMed  Google Scholar 

Wu Z, Zhang S, Cao Y, Wang Q, Sun K, Zheng X (2023) Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study. Front Pharmacol 14:1209063. https://doi.org/10.3389/fphar.2023.1209063

Article  CAS  PubMed  PubMed Central